DOI: 10.5061/dryad.sn02v6xg7
title: Strategic delivery of Omega-3 fatty acids for modulating inflammatory neurodegenerative diseases

description: Objectives: Early-life inflammatory events like infections and injuries
 may predispose the brain to Alzheimer's disease (AD) by disrupting
 neurodevelopment and raising vulnerability. The association between early
 neuroinflammation and subsequent neurodegeneration leading to dementia
 remains unclear. We hypothesize that omega-3 (n-3) fatty acids (FA),
 especially eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA),
 positively regulate neuro-immune cells, preserving their cell membrane
 structure and metabolic homeostasis. Our study examined whether strategic
 delivery of n-3 FA via injectable n-3 triglycerides (TG) can influence
 microglial lipid metabolism to prevent or delay AD progression. Methods
 and results: We characterized n-3 treatment effects on modulating lipid
 and metabolic homeostasis in microglia during the critical window of brain
 development. Our preliminary studies on determining the effects of early
 n-3 treatment on brain cell homeostasis indicate that perinatal bolus n-3
 TG injections suppressed activation of gliosis-associated markers in young
 mice predisposed to AD (5xFAD) and yielded sustained regulatory effects on
 the expression of inflammatory molecules, such as interleukin-6 (Il6) and
 tumor necrosis factor-alpha (Tnfa), in adult brains. A significant
 increase in high-frequency ultrasonic vocalizations (USV) was observed in
 P6 5xFAD mice that received perinatal n-3 compared to vehicle control,
 implicating enhanced active communication patterns. Improvement in
 behavior deficits was observed in n-3-treated adult AD mice. Perinatal n-3
 TG treatment modified brain lipid composition in young offspring,
 increasing key membrane lipid species, such as phospholipids (PL) and
 lysophospholipids (lysoPL). Pro-inflammatory sphingolipids associated with
 neurodegeneration, including lactosylceramide, were significantly lower in
 mice treated with n-3 than those in saline-treated AD mice. Conclusions:
 Our study establishes a proof of principle for targeting brain immune cell
 metabolism with injectable n-3 TG to mitigate neuroinflammation in AD
 pathogenesis, paving the way for future research into early treatments for
 related central nervous system (CNS) disorders.
description: # Strategic Delivery of Omega-3 Fatty Acids for Modulating Inflammatory
 Neurodegenerative Diseases Data for the effect of n-3 fatty acids on
 inflammatory neurodegenerative diseases. The experiment was located in New
 York, USA. Contact Dr. Chuchun L. Chang
 ([cc617@cumc.columbia.edu](mailto:cc617@cumc.columbia.edu)) with any
 questions. Description of the data and file structure: Quantitative
 Real-time PCR Total ribonucleic acid (RNA) was isolated from the whole
 brain using Trizol reagent (Invitrogen). Single-stranded complementary
 deoxyribonucleic acid (cDNA) was synthesized using iScript reverse
 transcriptase (Bio-Rad). Relative quantification of messenger ribonucleic
 acid (mRNA) expression was determined by real-time qPCR with Fast SYBR
 Green PCR kit (Applied Biosystems) normalized to a housekeeping gene GAPDH
 on Thermal Cyclers (Bio-Rad). The difference between the target gene and
 the housekeeping gene Ct value (ΔΔCt) was calculated for all experiments.
 The expression of the target gene (linear value) was normalized to the
 housekeeping gene, which was determined by 2- (ΔΔCt)50. Open Fields We
 performed the Open Field tests to assess the spontaneous exploratory
 behavior of n-3-treated mice in a new environment, including locomotion
 and anxiety-related behaviors57. Each 4- to 5-month-old mouse had a
 30-minute session monitored by Activity Monitor Version 7 software (Med
 Associates Inc.). It was then placed in the center of a Plexiglas arena
 (27.31 x 27.31 x 20.32 cm, Med Associates ENV-510) under dim light (~5
 lux) for free exploration. Infrared beams along the arena's axes
 tracked movement, stereotypies, and time in the center zone (14.29 x 14.29
 cm). Data were analyzed in six 5-minute intervals. Arenas were cleaned
 with 70% ethanol and dried between trials. We performed the Y-Maze to
 assess short-term spatial memory in 4-month-old mice by leveraging their
 innate exploration behavior58. In the Y-maze experiment, mice were put to
 explore three arms with equal dimensions (35 cm long, 5 cm wide, 10 cm
 high), each marked with a different sticker (equal sign, bus, plane)59.
 During Trial 1, mice were familiarized with two arms for 10 minutes,
 separated by an opaque door, then placed in a holding cage for 10 minutes.
 In Trial 2, mice explored all three arms for 5 minutes. The movement was
 recorded using Ethovision XT 12 software. The preference score, indicating
 memory performance, is calculated as: Preference score = (time in novel
 arm / (time in novel arm + time in the familiar arm)) x 100. Y-maze In the
 Y-maze experiment, mice were put to explore three arms with equal
 dimensions (35 cm long, 5 cm wide, 10 cm high), each marked with a
 different sticker (equal sign, bus, plane)59. During Trial 1, mice were
 familiarized with two arms for 10 minutes, separated by an opaque door,
 then placed in a holding cage for 10 minutes. In Trial 2, mice explored
 all three arms for 5 minutes. The movement was recorded using Ethovision
 XT 12 software. The preference score, indicating memory performance, is
 calculated as: Preference score = (time in novel arm / (time in novel arm
 + time in the familiar arm)) x 100. Lipidomic The employed lipidomic
 investigation and analytical workflow utilized a state-of-the-art LC-MS/MS
 platform, integrating an Agilent 6490 Triple Quadrupole (QQQ) MS with an
 Agilent 1260 Infinity LC system at the Columbia Biomarker Core
 Laboratory65. Briefly, lipid extracts were prepared from cell lysates
 using a chloroform-methanol extraction method and spiked with appropriate
 internal standards and analyzed on a platform comprising Agilent 1260
 Infinity HPLC integrated to Agilent 6490A QQQ mass spectrometer controlled
 by Masshunter v 7.0 (Agilent Technologies) as described before66. Tree
 panels, scanning for either positive lipids, negative lipids or neutral
 lipids (under positive mode), were analyzed. Equal amounts of internal
 standards with known concentrations were spiked into each extract. Each
 standard was later used to calculate the concentrations of corresponding
 lipid classes by first calculating the ratio between the measured
 intensities of a lipid species and that of the corresponding internal
 standard multiplied by the known concentration of the internal standard.
 Lipid levels for each sample were calculated as nmol normalized for
 protein concentration (nmol/mg protein). Data files include: ## qPCR
 7day.csv This file contains data on the expression of inflammatory
 cytokines in 7-day-old 5xFAD mice treated with and without omega-3 fatty
 acids. All data were collected by the authors. Blank cells indicate
 missing data. | variables | units | description | | :--------- |
 :---------: |
 :-------------------------------------------------------------------------------------------------- | | Identifier | categorical | the name of mice | | Ct | number | Cycle threshold value from qPCR analysis, representing the point at which amplification is detected | | Ave Ct | number | Average cycle threshold value across replicates in qPCR, indicating the relative expression level | ## qPCR 4-5m.csv This file contains data on the expression of inflammatory cytokines in 4-5-month-old 5xFAD mice treated with and without omega-3 fatty acids. All data were collected by the authors. Blank cells indicate missing data. | variables | units | description | | :--------- | :---------: | :-------------------------------------------------------------------------------------------------- | | Identifier | categorical | the name of mice | | Ct | number | Cycle threshold value from qPCR analysis, representing the point at which amplification is detected | | Ave Ct | number | Average cycle threshold value across replicates in qPCR, indicating the relative expression level | ## Open Field Summary.csv This file contains data on locomotor activity and exploratory behavior in WT and 5xFAD mice, assessed across various activity zones. All data were collected by the authors. Blank cells indicate missing data. | variables | units | description | | :------------------------ | :-----------: | :-------------------------------------------------------- | | Group | categorical | the group to which the subject belongs | | Subject | categorical | the identifier for the subject | | Gender | categorical | the gender of the subject | | Genotype | categorical | the genotype of the subject | | Ambulatory Distance Bin 1 | distance (cm) | distance traveled by the subject in Bin 1 | | Ambulatory Distance Bin 2 | distance (cm) | distance traveled by the subject in Bin 2 | | Ambulatory Distance Bin 3 | distance (cm) | distance traveled by the subject in Bin 3 | | Ambulatory Distance Bin 4 | distance (cm) | distance traveled by the subject in Bin 4 | | Ambulatory Distance Bin 5 | distance (cm) | distance traveled by the subject in Bin 5 | | Ambulatory Distance Bin 6 | distance (cm) | distance traveled by the subject in Bin 6 | | Vertical Counts Bin 1 | count | vertical counts recorded by the subject in Bin 1 | | Vertical Counts Bin 2 | count | vertical counts recorded by the subject in Bin 2 | | Vertical Counts Bin 3 | count | vertical counts recorded by the subject in Bin 3 | | Vertical Counts Bin 4 | count | vertical counts recorded by the subject in Bin 4 | | Vertical Counts Bin 5 | count | vertical counts recorded by the subject in Bin 5 | | Vertical Counts Bin 6 | count | vertical counts recorded by the subject in Bin 6 | | Duration Bin 1 Zone 1 | time (s) | duration spent by the subject in Zone 1 of activity Bin 1 | | Duration Bin 2 Zone 1 | time (s) | duration spent by the subject in Zone 1 of activity Bin 2 | | Duration Bin 3 Zone 1 | time (s) | duration spent by the subject in Zone 1 of activity Bin 3 | | Duration Bin 4 Zone 1 | time (s) | duration spent by the subject in Zone 1 of activity Bin 4 | | Duration Bin 5 Zone 1 | time (s) | duration spent by the subject in Zone 1 of activity Bin 5 | | Duration Bin 6 Zone 1 | time (s) | duration spent by the subject in Zone 1 of activity Bin 6 | ## Y-Maze-Summary.csv This file contains data on the Y-maze test conducted on 4-10-month-old 5xFAD mice with and without omega-3 fatty acid treatment. The dataset includes information on spontaneous alternation, zone alternation, and arm entry behavior. All data were collected by the authors. Blank cells indicate missing data. | variables | units | description | | :------------------------------------------------- | :---------: | :------------------------------------------------- | | Treatment | categorical | Experimental treatment condition | | Trial | categorical | Trial number of the experiment | | Age | categorical | Age of the animal | | Animal ID | categorical | Unique identifier for each animal | | Baited arm | categorical | The baited arm in the experiment | | Genotype | categorical | Genotype of the animal | | Zone alternation: center-point / Max alternations | frequency | Maximum alternations in the center-point | | % Spontaneous Alternation | percentage | Percentage of spontaneous alternation | | Zone alternation: center-point / Direct revisits | frequency | Number of direct revisits to the center-point | | Zone alternation: center-point / Indirect revisits | frequency | Number of indirect revisits to the center-point | | In zone A / center-point | frequency | Number of times the animal entered zone A | | In zone B / center-point | frequency | Number of times the animal entered zone B | | In zone Center / center-point | frequency | Number of times the animal entered the center zone | | In zone C / center-point | frequency | Number of times the animal entered zone C | | Total arms entries | frequency | Total number of arm entries in the test | ## Lipidomic-nmole.csv This file contains data on the lipid concentration profiles in 5xFAD mice, with a focus on lipid species and classes following omega-3 fatty acid treatment. All data were collected by the authors. All numerical values in this dataset represent lipid concentrations, measured in nmol/mg, normalized to protein concentration. | variables | units | description | | :------------------- | :-----: | :--------------------------------------------------------------------------------------------------- | | FC | nmol/mg | Concentration of free cholesterol in the sample | | CE | nmol/mg | Concentration of cholesterol esters in the sample | | AC | nmol/mg | Concentration of acylcarnitines in the sample | | MG | nmol/mg | Concentration of monoglycerides in the sample | | DG | nmol/mg | Concentration of diglycerides in the sample | | TG | nmol/mg | Concentration of triglycerides in the sample | | Cer | nmol/mg | Concentration of ceramides in the sample | | dhCer | nmol/mg | Concentration of dihydroceramides in the sample | | SM | nmol/mg | Concentration of sphingomyelins in the sample | | dhSM | nmol/mg | Concentration of dihydrosphingomyelins in the sample | | MhCer | nmol/mg | Concentration of monohexosylceramides in the sample | | Sulf | nmol/mg | Concentration of sulfoglycosphingolipids in the sample | | LacCer | nmol/mg | Concentration of lactosylceramides in the sample | | GM3 | nmol/mg | Concentration of GM3 gangliosides in the sample | | GB3 | nmol/mg | Concentration of GB3 gangliosides in the sample | | PA | nmol/mg | Concentration of phosphatidic acid in the sample | | PC | nmol/mg | Concentration of phosphatidylcholine in the sample | | PCe | nmol/mg | Concentration of phosphatidylethanolamine in the sample | | PE | nmol/mg | Concentration of phosphatidylethanolamine in the sample | | PEp | nmol/mg | Concentration of phosphatidylserine in the sample | | PS | nmol/mg | Concentration of phosphatidylserine in the sample | | PI | nmol/mg | Concentration of phosphatidylinositol in the sample | | PG | nmol/mg | Concentration of phosphatidylglycerol in the sample | | BMP | nmol/mg | Concentration of bis(monoacylglycerol) phosphate in the sample | | AcylPG | nmol/mg | Concentration of acylphosphatidylglycerol in the sample | | LPC | nmol/mg | Concentration of lysophosphatidylcholine in the sample | | LPCe | nmol/mg | Concentration of lysophosphatidylethanolamine in the sample | | LPE | nmol/mg | Concentration of lysophosphatidylethanolamine in the sample | | LPEp | nmol/mg | Concentration of lysophosphatidylserine in the sample | | LPI | nmol/mg | Concentration of lysophosphoinositol in the sample | | LPS | nmol/mg | Concentration of lysophosphatidylserine in the sample | | NAPE | nmol/mg | Concentration of N-acylphosphatidylethanolamines in the sample | | NAPS | nmol/mg | Concentration of N-acylphosphatidylserines in the sample | | NSer | nmol/mg | Concentration of N-acylserines in the sample | | CE 16:0 | nmol/mg | Concentration of cholesterol ester with 16:0 fatty acid | | CE 16:1 | nmol/mg | Concentration of cholesterol ester with 16:1 fatty acid | | CE 18:0 | nmol/mg | Concentration of cholesterol ester with 18:0 fatty acid | | CE 18:1 | nmol/mg | Concentration of cholesterol ester with 18:1 fatty acid | | CE 18:2 | nmol/mg | Concentration of cholesterol ester with 18:2 fatty acid | | CE 20:0 | nmol/mg | Concentration of cholesterol ester with 20:0 fatty acid | | CE 20:1 | nmol/mg | Concentration of cholesterol ester with 20:1 fatty acid | | CE 20:2 | nmol/mg | Concentration of cholesterol ester with 20:2 fatty acid | | CE 20:3 | nmol/mg | Concentration of cholesterol ester with 20:3 fatty acid | | CE 20:4 | nmol/mg | Concentration of cholesterol ester with 20:4 fatty acid | | CE 22:2 | nmol/mg | Concentration of cholesterol ester with 22:2 fatty acid | | CE 22:3 | nmol/mg | Concentration of cholesterol ester with 22:3 fatty acid | | CE 22:4 | nmol/mg | Concentration of cholesterol ester with 22:4 fatty acid | | CE 22:5 | nmol/mg | Concentration of cholesterol ester with 22:5 fatty acid | | CE 22:6 | nmol/mg | Concentration of cholesterol ester with 22:6 fatty acid | | CE 24:2 | nmol/mg | Concentration of cholesterol ester with 24:2 fatty acid | | CE 24:3 | nmol/mg | Concentration of cholesterol ester with 24:3 fatty acid | | CE 24:4 | nmol/mg | Concentration of cholesterol ester with 24:4 fatty acid | | CE 24:5 | nmol/mg | Concentration of cholesterol ester with 24:5 fatty acid | | CE 24:6 | nmol/mg | Concentration of cholesterol ester with 24:6 fatty acid | | AC C12:0 | nmol/mg | Concentration of acylcarnitine with C12:0 fatty acid | | AC C14:0 | nmol/mg | Concentration of acylcarnitine with C14:0 fatty acid | | AC C16:0 | nmol/mg | Concentration of acylcarnitine with C16:0 fatty acid | | AC C18:0 | nmol/mg | Concentration of acylcarnitine with C18:0 fatty acid | | AC C18:1 | nmol/mg | Concentration of acylcarnitine with C18:1 fatty acid | | AC C2:0 | nmol/mg | Concentration of acylcarnitine with C2:0 fatty acid | | AC C3:0 | nmol/mg | Concentration of acylcarnitine with C3:0 fatty acid | | AC C6:0 | nmol/mg | Concentration of acylcarnitine with C6:0 fatty acid | | AC C8:0 | nmol/mg | Concentration of acylcarnitine with C8:0 fatty acid | | MG 16:0 | nmol/mg | Concentration of monoglyceride with 16:0 fatty acid | | MG 16:1 | nmol/mg | Concentration of monoglyceride with 16:1 fatty acid | | MG 18:0 | nmol/mg | Concentration of monoglyceride with 18:0 fatty acid | | MG 18:1 | nmol/mg | Concentration of monoglyceride with 18:1 fatty acid | | MG 18:2 | nmol/mg | Concentration of monoglyceride with 18:2 fatty acid | | MG 18:3 | nmol/mg | Concentration of monoglyceride with 18:3 fatty acid | | MG 20:0 | nmol/mg | Concentration of monoglyceride with 20:0 fatty acid | | MG 20:1 | nmol/mg | Concentration of monoglyceride with 20:1 fatty acid | | MG 20:2 | nmol/mg | Concentration of monoglyceride with 20:2 fatty acid | | MG 20:3 | nmol/mg | Concentration of monoglyceride with 20:3 fatty acid | | MG 20:4 | nmol/mg | Concentration of monoglyceride with 20:4 fatty acid | | MG 22:0 | nmol/mg | Concentration of monoglyceride with 22:0 fatty acid | | MG 22:1 | nmol/mg | Concentration of monoglyceride with 22:1 fatty acid | | MG 22:2 | nmol/mg | Concentration of monoglyceride with 22:2 fatty acid | | MG 22:3 | nmol/mg | Concentration of monoglyceride with 22:3 fatty acid | | MG 22:4 | nmol/mg | Concentration of monoglyceride with 22:4 fatty acid | | MG 22:5 | nmol/mg | Concentration of monoglyceride with 22:5 fatty acid | | MG 22:6 | nmol/mg | Concentration of monoglyceride with 22:6 fatty acid | | DG 30:0/14:0 | nmol/mg | Concentration of diglyceride with 30:0/14:0 fatty acid | | DG 30:1/14:0 | nmol/mg | Concentration of diglyceride with 30:1/14:0 fatty acid | | DG 32:0/16:0 | nmol/mg | Concentration of diglyceride with 32:0/16:0 fatty acid | | DG 32:1/16:0 | nmol/mg | Concentration of diglyceride with 32:1/16:0 fatty acid | | DG 32:2/16:1 | nmol/mg | Concentration of diglyceride with 32:2/16:1 fatty acid | | DG 34:0/16:0 | nmol/mg | Concentration of diglyceride with 34:0/16:0 fatty acid | | DG 34:1/16:0 | nmol/mg | Concentration of diglyceride with 34:1/16:0 fatty acid | | DG 34:2/16:0 | nmol/mg | Concentration of diglyceride with 34:2/16:0 fatty acid | | DG 34:2/16:1 | nmol/mg | Concentration of diglyceride with 34:2/16:1 fatty acid | | DG 36:0/18:0 | nmol/mg | Concentration of diglyceride with 36:0/18:0 fatty acid | | DG 36:1/18:0 | nmol/mg | Concentration of diglyceride with 36:1/18:0 fatty acid | | DG 36:2/18:0 | nmol/mg | Concentration of diglyceride with 36:2/18:0 fatty acid | | DG 36:2/18:1 | nmol/mg | Concentration of diglyceride with 36:2/18:1 fatty acid | | DG 36:3/18:1 | nmol/mg | Concentration of diglyceride with 36:3/18:1 fatty acid | | DG 36:4/18:0 | nmol/mg | Concentration of diglyceride with 36:4/18:0 fatty acid | | DG 38:1/18:0 | nmol/mg | Concentration of diglyceride with 38:1/18:0 fatty acid | | DG 38:2/18:0 | nmol/mg | Concentration of diglyceride with 38:2/18:0 fatty acid | | DG 38:2/18:1 | nmol/mg | Concentration of diglyceride with 38:2/18:1 fatty acid | | DG 38:3/18:0 | nmol/mg | Concentration of diglyceride with 38:3/18:0 fatty acid | | DG 38:3/18:1 | nmol/mg | Concentration of diglyceride with 38:3/18:1 fatty acid | | DG 38:4/18:0 | nmol/mg | Concentration of diglyceride with 38:4/18:0 fatty acid | | DG 38:4/18:1 | nmol/mg | Concentration of diglyceride with 38:4/18:1 fatty acid | | DG 40:4/18:0 | nmol/mg | Concentration of diglyceride with 40:4/18:0 fatty acid | | DG 40:4/18:1 | nmol/mg | Concentration of diglyceride with 40:4/18:1 fatty acid | | DG 40:5/18:0 | nmol/mg | Concentration of diglyceride with 40:5/18:0 fatty acid | | DG 40:5/18:1 | nmol/mg | Concentration of diglyceride with 40:5/18:1 fatty acid | | DG 40:6/18:0 | nmol/mg | Concentration of diglyceride with 40:6/18:0 fatty acid | | DG 40:6/18:1 | nmol/mg | Concentration of diglyceride with 40:6/18:1 fatty acid | | TG 48:0/16:0 | nmol/mg | Concentration of triglyceride with 48:0/16:0 fatty acid | | TG 48:1/16:0 | nmol/mg | Concentration of triglyceride with 48:1/16:0 fatty acid | | TG 50:0/16:0 | nmol/mg | Concentration of triglyceride with 50:0/16:0 fatty acid | | TG 50:1/16:1 | nmol/mg | Concentration of triglyceride with 50:1/16:1 fatty acid | | TG 50:2/16:1 | nmol/mg | Concentration of triglyceride with 50:2/16:1 fatty acid | | TG 50:3/16:1 | nmol/mg | Concentration of triglyceride with 50:3/16:1 fatty acid | | TG 52:0/18:0 | nmol/mg | Concentration of triglyceride with 52:0/18:0 fatty acid | | TG 52:1/18:0 | nmol/mg | Concentration of triglyceride with 52:1/18:0 fatty acid | | TG 52:2/18:0 | nmol/mg | Concentration of triglyceride with 52:2/18:0 fatty acid | | TG 52:3/18:1 | nmol/mg | Concentration of triglyceride with 52:3/18:1 fatty acid | | TG 52:4/18:1 | nmol/mg | Concentration of triglyceride with 52:4/18:1 fatty acid | | TG 52:5/18:1 | nmol/mg | Concentration of triglyceride with 52:5/18:1 fatty acid | | TG 52:5/20:4 | nmol/mg | Concentration of triglyceride with 52:5/20:4 fatty acid | | TG 54:0/18:0 | nmol/mg | Concentration of triglyceride with 54:0/18:0 fatty acid | | TG 54:1/18:0 | nmol/mg | Concentration of triglyceride with 54:1/18:0 fatty acid | | TG 54:2/18:0 | nmol/mg | Concentration of triglyceride with 54:2/18:0 fatty acid | | TG 54:3/18:0 | nmol/mg | Concentration of triglyceride with 54:3/18:0 fatty acid | | TG 54:4/18:1 | nmol/mg | Concentration of triglyceride with 54:4/18:1 fatty acid | | TG 54:4/20:4 | nmol/mg | Concentration of triglyceride with 54:4/20:4 fatty acid | | TG 54:5/18:1 | nmol/mg | Concentration of triglyceride with 54:5/18:1 fatty acid | | TG 54:5/20:4 | nmol/mg | Concentration of triglyceride with 54:5/20:4 fatty acid | | TG 54:6/18:1 | nmol/mg | Concentration of triglyceride with 54:6/18:1 fatty acid | | TG 54:6/20:4 | nmol/mg | Concentration of triglyceride with 54:6/20:4 fatty acid | | TG 54:7/18:1 | nmol/mg | Concentration of triglyceride with 54:7/18:1 fatty acid | | TG 54:7/20:4 | nmol/mg | Concentration of triglyceride with 54:7/20:4 fatty acid | | TG 56:3/18:1 | nmol/mg | Concentration of triglyceride with 56:3/18:1 fatty acid | | TG 56:4/18:1 | nmol/mg | Concentration of triglyceride with 56:4/18:1 fatty acid | | TG 56:4/20:4 | nmol/mg | Concentration of triglyceride with 56:4/20:4 fatty acid | | TG 56:5/18:1 | nmol/mg | Concentration of triglyceride with 56:5/18:1 fatty acid | | TG 56:5/20:4 | nmol/mg | Concentration of triglyceride with 56:5/20:4 fatty acid | | TG 56:6/20:4 | nmol/mg | Concentration of triglyceride with 56:6/20:4 fatty acid | | TG 56:7/20:4 | nmol/mg | Concentration of triglyceride with 56:7/20:4 fatty acid | | TG 56:8/20:4 | nmol/mg | Concentration of triglyceride with 56:8/20:4 fatty acid | | TG 56:9/20:4 | nmol/mg | Concentration of triglyceride with 56:9/20:4 fatty acid | | TG 58:5/20:4 | nmol/mg | Concentration of triglyceride with 58:5/20:4 fatty acid | | TG 58:6/20:4 | nmol/mg | Concentration of triglyceride with 58:6/20:4 fatty acid | | TG 58:7/20:4 | nmol/mg | Concentration of triglyceride with 58:7/20:4 fatty acid | | TG 58:8/22:6 | nmol/mg | Concentration of triglyceride with 58:8/22:6 fatty acid | | TG 58:9/22:6 | nmol/mg | Concentration of triglyceride with 58:9/22:6 fatty acid | | TG 60:7/22:6 | nmol/mg | Concentration of triglyceride with 60:7/22:6 fatty acid | | TG 60:8/22:6 | nmol/mg | Concentration of triglyceride with 60:8/22:6 fatty acid | | TG 60:9/22:6 | nmol/mg | Concentration of triglyceride with 60:9/22:6 fatty acid | | dhCer d18:0/16:0 | nmol/mg | Concentration of dihydroceramide with d18:0/16:0 fatty acid | | dhCer d18:0/16:1 | nmol/mg | Concentration of dihydroceramide with d18:0/16:1 fatty acid | | dhCer d18:0/18:0 | nmol/mg | Concentration of dihydroceramide with d18:0/18:0 fatty acid | | dhCer d18:0/18:1 | nmol/mg | Concentration of dihydroceramide with d18:0/18:1 fatty acid | | dhCer d18:0/20:0 | nmol/mg | Concentration of dihydroceramide with d18:0/20:0 fatty acid | | dhCer d18:0/20:1 | nmol/mg | Concentration of dihydroceramide with d18:0/20:1 fatty acid | | dhCer d18:0/22:0 | nmol/mg | Concentration of dihydroceramide with d18:0/22:0 fatty acid | | dhCer d18:0/22:1 | nmol/mg | Concentration of dihydroceramide with d18:0/22:1 fatty acid | | dhCer d18:0/24:0 | nmol/mg | Concentration of dihydroceramide with d18:0/24:0 fatty acid | | dhCer d18:0/24:1 | nmol/mg | Concentration of dihydroceramide with d18:0/24:1 fatty acid | | dhCer d18:0/26:0 | nmol/mg | Concentration of dihydroceramide with d18:0/26:0 fatty acid | | dhCer d18:0/26:1 | nmol/mg | Concentration of dihydroceramide with d18:0/26:1 fatty acid | | Cer d18:1/16:0 | nmol/mg | Concentration of ceramide with d18:1/16:0 fatty acid | | Cer d18:1/16:1 | nmol/mg | Concentration of ceramide with d18:1/16:1 fatty acid | | Cer d18:1/18:0 | nmol/mg | Concentration of ceramide with d18:1/18:0 fatty acid | | Cer d18:1/18:1 | nmol/mg | Concentration of ceramide with d18:1/18:1 fatty acid | | Cer d18:1/20:0 | nmol/mg | Concentration of ceramide with d18:1/20:0 fatty acid | | Cer d18:1/20:1 | nmol/mg | Concentration of ceramide with d18:1/20:1 fatty acid | | Cer d18:1/22:0 | nmol/mg | Concentration of ceramide with d18:1/22:0 fatty acid | | Cer d18:1/22:1 | nmol/mg | Concentration of ceramide with d18:1/22:1 fatty acid | | Cer d18:1/24:0 | nmol/mg | Concentration of ceramide with d18:1/24:0 fatty acid | | Cer d18:1/24:1 | nmol/mg | Concentration of ceramide with d18:1/24:1 fatty acid | | Cer d18:1/26:0 | nmol/mg | Concentration of ceramide with d18:1/26:0 fatty acid | | Cer d18:1/26:1 | nmol/mg | Concentration of ceramide with d18:1/26:1 fatty acid | | SM d18:1/16:0 | nmol/mg | Concentration of sphingomyelin with d18:1/16:0 fatty acid | | SM d18:1/16:1 | nmol/mg | Concentration of sphingomyelin with d18:1/16:1 fatty acid | | SM d18:1/18:0 | nmol/mg | Concentration of sphingomyelin with d18:1/18:0 fatty acid | | SM d18:1/18:1 | nmol/mg | Concentration of sphingomyelin with d18:1/18:1 fatty acid | | SM d18:1/20:0 | nmol/mg | Concentration of sphingomyelin with d18:1/20:0 fatty acid | | SM d18:1/20:1 | nmol/mg | Concentration of sphingomyelin with d18:1/20:1 fatty acid | | SM d18:1/22:0 | nmol/mg | Concentration of sphingomyelin with d18:1/22:0 fatty acid | | SM d18:1/22:1 | nmol/mg | Concentration of sphingomyelin with d18:1/22:1 fatty acid | | SM d18:1/24:0 | nmol/mg | Concentration of sphingomyelin with d18:1/24:0 fatty acid | | SM d18:1/24:1 | nmol/mg | Concentration of sphingomyelin with d18:1/24:1 fatty acid | | SM d18:1/26:0 | nmol/mg | Concentration of sphingomyelin with d18:1/26:0 fatty acid | | SM d18:1/26:1 | nmol/mg | Concentration of sphingomyelin with d18:1/26:1 fatty acid | | dhSM d18:0/16:0 | nmol/mg | Concentration of dihydrosphingomyelin with d18:0/16:0 fatty acid | | dhSM d18:0/16:1 | nmol/mg | Concentration of dihydrosphingomyelin with d18:0/16:1 fatty acid | | dhSM d18:0/18:0 | nmol/mg | Concentration of dihydrosphingomyelin with d18:0/18:0 fatty acid | | dhSM d18:0/18:1 | nmol/mg | Concentration of dihydrosphingomyelin with d18:0/18:1 fatty acid | | dhSM d18:0/20:0 | nmol/mg | Concentration of dihydrosphingomyelin with d18:0/20:0 fatty acid | | dhSM d18:0/20:1 | nmol/mg | Concentration of dihydrosphingomyelin with d18:0/20:1 fatty acid | | dhSM d18:0/22:0 | nmol/mg | Concentration of dihydrosphingomyelin with d18:0/22:0 fatty acid | | dhSM d18:0/22:1 | nmol/mg | Concentration of dihydrosphingomyelin with d18:0/22:1 fatty acid | | dhSM d18:0/24:0 | nmol/mg | Concentration of dihydrosphingomyelin with d18:0/24:0 fatty acid | | dhSM d18:0/24:1 | nmol/mg | Concentration of dihydrosphingomyelin with d18:0/24:1 fatty acid | | dhSM d18:0/26:0 | nmol/mg | Concentration of dihydrosphingomyelin with d18:0/26:0 fatty acid | | dhSM d18:0/26:1 | nmol/mg | Concentration of dihydrosphingomyelin with d18:0/26:1 fatty acid | | MhCer d18:0/16:0 | nmol/mg | Concentration of monohydroceramide with d18:0/16:0 fatty acid | | MhCer d18:0/16:1 | nmol/mg | Concentration of monohydroceramide with d18:0/16:1 fatty acid | | MhCer d18:0/18:0 | nmol/mg | Concentration of monohydroceramide with d18:0/18:0 fatty acid | | MhCer d18:0/18:1 | nmol/mg | Concentration of monohydroceramide with d18:0/18:1 fatty acid | | MhCer d18:0/20:0 | nmol/mg | Concentration of monohydroceramide with d18:0/20:0 fatty acid | | MhCer d18:0/20:1 | nmol/mg | Concentration of monohydroceramide with d18:0/20:1 fatty acid | | MhCer d18:0/22:0 | nmol/mg | Concentration of monohydroceramide with d18:0/22:0 fatty acid | | MhCer d18:0/22:1 | nmol/mg | Concentration of monohydroceramide with d18:0/22:1 fatty acid | | MhCer d18:0/24:0 | nmol/mg | Concentration of monohydroceramide with d18:0/24:0 fatty acid | | MhCer d18:0/24:1 | nmol/mg | Concentration of monohydroceramide with d18:0/24:1 fatty acid | | MhCer d18:0/26:0 | nmol/mg | Concentration of monohydroceramide with d18:0/26:0 fatty acid | | MhCer d18:0/26:1 | nmol/mg | Concentration of monohydroceramide with d18:0/26:1 fatty acid | | MhCer d18:1/16:0 | nmol/mg | Concentration of monohydroceramide with d18:1/16:0 fatty acid | | MhCer d18:1/16:1 | nmol/mg | Concentration of monohydroceramide with d18:1/16:1 fatty acid | | MhCer d18:1/18:0 | nmol/mg | Concentration of monohydroceramide with d18:1/18:0 fatty acid | | MhCer d18:1/18:1 | nmol/mg | Concentration of monohydroceramide with d18:1/18:1 fatty acid | | MhCer d18:1/20:0 | nmol/mg | Concentration of monohydroceramide with d18:1/20:0 fatty acid | | MhCer d18:1/20:1 | nmol/mg | Concentration of monohydroceramide with d18:1/20:1 fatty acid | | MhCer d18:1/22:0 | nmol/mg | Concentration of monohydroceramide with d18:1/22:0 fatty acid | | MhCer d18:1/22:1 | nmol/mg | Concentration of monohydroceramide with d18:1/22:1 fatty acid | | Sulf d18:0/16:0 | nmol/mg | Concentration of sulfatide with d18:0/16:0 fatty acid | | Sulf d18:0/18:0 | nmol/mg | Concentration of sulfatide with d18:0/18:0 fatty acid | | Sulf d18:0/20:0 | nmol/mg | Concentration of sulfatide with d18:0/20:0 fatty acid | | Sulf d18:0/22:0 | nmol/mg | Concentration of sulfatide with d18:0/22:0 fatty acid | | Sulf d18:0/24:0 | nmol/mg | Concentration of sulfatide with d18:0/24:0 fatty acid | | Sulf d18:0/26:0 | nmol/mg | Concentration of sulfatide with d18:0/26:0 fatty acid | | Sulf d18:1/16:0 | nmol/mg | Concentration of sulfatide with d18:1/16:0 fatty acid | | Sulf d18:1/16:1 | nmol/mg | Concentration of sulfatide with d18:1/16:1 fatty acid | | Sulf d18:1/18:0 | nmol/mg | Concentration of sulfatide with d18:1/18:0 fatty acid | | Sulf d18:1/18:1 | nmol/mg | Concentration of sulfatide with d18:1/18:1 fatty acid | | Sulf d18:1/20:0 | nmol/mg | Concentration of sulfatide with d18:1/20:0 fatty acid | | Sulf d18:1/20:1 | nmol/mg | Concentration of sulfatide with d18:1/20:1 fatty acid | | Sulf d18:1/22:0 | nmol/mg | Concentration of sulfatide with d18:1/22:0 fatty acid | | Sulf d18:1/22:1 | nmol/mg | Concentration of sulfatide with d18:1/22:1 fatty acid | | LacCer d18:0/16:0 | nmol/mg | Concentration of lactosylceramide with d18:0/16:0 fatty acid | | LacCer d18:0/16:1 | nmol/mg | Concentration of lactosylceramide with d18:0/16:1 fatty acid | | LacCer d18:0/18:0 | nmol/mg | Concentration of lactosylceramide with d18:0/18:0 fatty acid | | LacCer d18:0/18:1 | nmol/mg | Concentration of lactosylceramide with d18:0/18:1 fatty acid | | LacCer d18:0/20:0 | nmol/mg | Concentration of lactosylceramide with d18:0/20:0 fatty acid | | LacCer d18:0/20:1 | nmol/mg | Concentration of lactosylceramide with d18:0/20:1 fatty acid | | LacCer d18:0/22:0 | nmol/mg | Concentration of lactosylceramide with d18:0/22:0 fatty acid | | LacCer d18:0/22:1 | nmol/mg | Concentration of lactosylceramide with d18:0/22:1 fatty acid | | LacCer d18:0/24:0 | nmol/mg | Concentration of lactosylceramide with d18:0/24:0 fatty acid | | LacCer d18:0/24:1 | nmol/mg | Concentration of lactosylceramide with d18:0/24:1 fatty acid | | LacCer d18:0/26:0 | nmol/mg | Concentration of lactosylceramide with d18:0/26:0 fatty acid | | LacCer d18:0/26:1 | nmol/mg | Concentration of lactosylceramide with d18:0/26:1 fatty acid | | LacCer d18:1/16:0 | nmol/mg | Concentration of lactosylceramide with d18:1/16:0 fatty acid | | LacCer d18:1/16:1 | nmol/mg | Concentration of lactosylceramide with d18:1/16:1 fatty acid | | LacCer d18:1/18:0 | nmol/mg | Concentration of lactosylceramide with d18:1/18:0 fatty acid | | LacCer d18:1/18:1 | nmol/mg | Concentration of lactosylceramide with d18:1/18:1 fatty acid | | LacCer d18:1/20:0 | nmol/mg | Concentration of lactosylceramide with d18:1/20:0 fatty acid | | LacCer d18:1/20:1 | nmol/mg | Concentration of lactosylceramide with d18:1/20:1 fatty acid | | LacCer d18:1/22:0 | nmol/mg | Concentration of lactosylceramide with d18:1/22:0 fatty acid | | LacCer d18:1/22:1 | nmol/mg | Concentration of lactosylceramide with d18:1/22:1 fatty acid | | LacCer d18:1/24:0 | nmol/mg | Concentration of lactosylceramide with d18:1/24:0 fatty acid | | LacCer d18:1/24:1 | nmol/mg | Concentration of lactosylceramide with d18:1/24:1 fatty acid | | GM3 d18:0/16:0 | nmol/mg | Concentration of GM3 ganglioside with d18:0/16:0 fatty acid | | GM3 d18:0/18:0 | nmol/mg | Concentration of GM3 ganglioside with d18:0/18:0 fatty acid | | GM3 d18:0/20:0 | nmol/mg | Concentration of GM3 ganglioside with d18:0/20:0 fatty acid | | GM3 d18:0/22:0 | nmol/mg | Concentration of GM3 ganglioside with d18:0/22:0 fatty acid | | GM3 d18:0/24:0 | nmol/mg | Concentration of GM3 ganglioside with d18:0/24:0 fatty acid | | GM3 d18:0/26:0 | nmol/mg | Concentration of GM3 ganglioside with d18:0/26:0 fatty acid | | GM3 d18:1/16:0 | nmol/mg | Concentration of GM3 ganglioside with d18:1/16:0 fatty acid | | GM3 d18:1/16:1 | nmol/mg | Concentration of GM3 ganglioside with d18:1/16:1 fatty acid | | GM3 d18:1/18:0 | nmol/mg | Concentration of GM3 ganglioside with d18:1/18:0 fatty acid | | GM3 d18:1/18:1 | nmol/mg | Concentration of GM3 ganglioside with d18:1/18:1 fatty acid | | GM3 d18:1/20:0 | nmol/mg | Concentration of GM3 ganglioside with d18:1/20:0 fatty acid | | GM3 d18:1/20:1 | nmol/mg | Concentration of GM3 ganglioside with d18:1/20:1 fatty acid | | GM3 d18:1/22:0 | nmol/mg | Concentration of GM3 ganglioside with d18:1/22:0 fatty acid | | GM3 d18:1/22:1 | nmol/mg | Concentration of GM3 ganglioside with d18:1/22:1 fatty acid | | GB3 d18:1/16:0 | nmol/mg | Concentration of GB3 ganglioside with d18:1/16:0 fatty acid | | GB3 d18:1/16:1 | nmol/mg | Concentration of GB3 ganglioside with d18:1/16:1 fatty acid | | GB3 d18:1/18:0 | nmol/mg | Concentration of GB3 ganglioside with d18:1/18:0 fatty acid | | GB3 d18:1/18:1 | nmol/mg | Concentration of GB3 ganglioside with d18:1/18:1 fatty acid | | GB3 d18:1/20:0 | nmol/mg | Concentration of GB3 ganglioside with d18:1/20:0 fatty acid | | GB3 d18:1/20:1 | nmol/mg | Concentration of GB3 ganglioside with d18:1/20:1 fatty acid | | GB3 d18:1/22:0 | nmol/mg | Concentration of GB3 ganglioside with d18:1/22:0 fatty acid | | GB3 d18:1/22:1 | nmol/mg | Concentration of GB3 ganglioside with d18:1/22:1 fatty acid | | GB3 d18:1/24:0 | nmol/mg | Concentration of GB3 ganglioside with d18:1/24:0 fatty acid | | GB3 d18:1/24:1 | nmol/mg | Concentration of GB3 ganglioside with d18:1/24:1 fatty acid | | PA 30:0 | nmol/mg | Concentration of phosphatidic acid with 30:0 fatty acid | | PA 32:0 | nmol/mg | Concentration of phosphatidic acid with 32:0 fatty acid | | PA 32:1 | nmol/mg | Concentration of phosphatidic acid with 32:1 fatty acid | | PA 34:0 | nmol/mg | Concentration of phosphatidic acid with 34:0 fatty acid | | PA 34:1 | nmol/mg | Concentration of phosphatidic acid with 34:1 fatty acid | | PA 34:2 | nmol/mg | Concentration of phosphatidic acid with 34:2 fatty acid | | PA 36:0 | nmol/mg | Concentration of phosphatidic acid with 36:0 fatty acid | | PA 36:1 | nmol/mg | Concentration of phosphatidic acid with 36:1 fatty acid | | PA 36:2 | nmol/mg | Concentration of phosphatidic acid with 36:2 fatty acid | | PA 36:3 | nmol/mg | Concentration of phosphatidic acid with 36:3 fatty acid | | PA 36:4 | nmol/mg | Concentration of phosphatidic acid with 36:4 fatty acid | | PA 38:0 | nmol/mg | Concentration of phosphatidic acid with 38:0 fatty acid | | PA 38:1 | nmol/mg | Concentration of phosphatidic acid with 38:1 fatty acid | | PA 38:2 | nmol/mg | Concentration of phosphatidic acid with 38:2 fatty acid | | PA 38:3 | nmol/mg | Concentration of phosphatidic acid with 38:3 fatty acid | | PA 38:4 | nmol/mg | Concentration of phosphatidic acid with 38:4 fatty acid | | PA 38:5 | nmol/mg | Concentration of phosphatidic acid with 38:5 fatty acid | | PA 38:6 | nmol/mg | Concentration of phosphatidic acid with 38:6 fatty acid | | PA 40:4 | nmol/mg | Concentration of phosphatidic acid with 40:4 fatty acid | | PA 40:5 | nmol/mg | Concentration of phosphatidic acid with 40:5 fatty acid | | PA 40:6 | nmol/mg | Concentration of phosphatidic acid with 40:6 fatty acid | | PA 40:7 | nmol/mg | Concentration of phosphatidic acid with 40:7 fatty acid | | PA 42:5 | nmol/mg | Concentration of phosphatidic acid with 42:5 fatty acid | | PA 42:6 | nmol/mg | Concentration of phosphatidic acid with 42:6 fatty acid | | PA 42:7 | nmol/mg | Concentration of phosphatidic acid with 42:7 fatty acid | | PC 30:0 | nmol/mg | Concentration of phosphatidylcholine with 30:0 fatty acid | | PC 32:0 | nmol/mg | Concentration of phosphatidylcholine with 32:0 fatty acid | | PC 32:1 | nmol/mg | Concentration of phosphatidylcholine with 32:1 fatty acid | | PC 34:0 | nmol/mg | Concentration of phosphatidylcholine with 34:0 fatty acid | | PC 34:1 | nmol/mg | Concentration of phosphatidylcholine with 34:1 fatty acid | | PC 34:2 | nmol/mg | Concentration of phosphatidylcholine with 34:2 fatty acid | | PC 36:0 | nmol/mg | Concentration of phosphatidylcholine with 36:0 fatty acid | | PC 36:1 | nmol/mg | Concentration of phosphatidylcholine with 36:1 fatty acid | | PC 36:2 | nmol/mg | Concentration of phosphatidylcholine with 36:2 fatty acid | | PC 36:3 | nmol/mg | Concentration of phosphatidylcholine with 36:3 fatty acid | | PC 36:4 | nmol/mg | Concentration of phosphatidylcholine with 36:4 fatty acid | | PC 38:0 | nmol/mg | Concentration of phosphatidylcholine with 38:0 fatty acid | | PC 38:1 | nmol/mg | Concentration of phosphatidylcholine with 38:1 fatty acid | | PC 38:2 | nmol/mg | Concentration of phosphatidylcholine with 38:2 fatty acid | | PC 38:3 | nmol/mg | Concentration of phosphatidylcholine with 38:3 fatty acid | | PC 38:4 | nmol/mg | Concentration of phosphatidylcholine with 38:4 fatty acid | | PC 38:5 | nmol/mg | Concentration of phosphatidylcholine with 38:5 fatty acid | | PC 38:6 | nmol/mg | Concentration of phosphatidylcholine with 38:6 fatty acid | | PC 40:4 | nmol/mg | Concentration of phosphatidylcholine with 40:4 fatty acid | | PC 40:5 | nmol/mg | Concentration of phosphatidylcholine with 40:5 fatty acid | | PC 40:6 | nmol/mg | Concentration of phosphatidylcholine with 40:6 fatty acid | | PC 40:7 | nmol/mg | Concentration of phosphatidylcholine with 40:7 fatty acid | | PC 42:5 | nmol/mg | Concentration of phosphatidylcholine with 42:5 fatty acid | | PC 42:6 | nmol/mg | Concentration of phosphatidylcholine with 42:6 fatty acid | | PC 42:7 | nmol/mg | Concentration of phosphatidylcholine with 42:7 fatty acid | | PCe 30:0 | nmol/mg | Concentration of phosphatidylethanolamine with 30:0 fatty acid | | PCe 32:0 | nmol/mg | Concentration of phosphatidylethanolamine with 32:0 fatty acid | | PCe 32:1 | nmol/mg | Concentration of phosphatidylethanolamine with 32:1 fatty acid | | PCe 34:0 | nmol/mg | Concentration of phosphatidylethanolamine with 34:0 fatty acid | | PCe 34:1 | nmol/mg | Concentration of phosphatidylethanolamine with 34:1 fatty acid | | PCe 34:2 | nmol/mg | Concentration of phosphatidylethanolamine with 34:2 fatty acid | | PCe 36:0 | nmol/mg | Concentration of phosphatidylethanolamine with 36:0 fatty acid | | PCe 36:1 | nmol/mg | Concentration of phosphatidylethanolamine with 36:1 fatty acid | | PCe 36:2 | nmol/mg | Concentration of phosphatidylethanolamine with 36:2 fatty acid | | PCe 36:3 | nmol/mg | Concentration of phosphatidylethanolamine with 36:3 fatty acid | | PCe 36:4 | nmol/mg | Concentration of phosphatidylethanolamine with 36:4 fatty acid | | PCe 38:0 | nmol/mg | Concentration of phosphatidylethanolamine with 38:0 fatty acid | | PCe 38:1 | nmol/mg | Concentration of phosphatidylethanolamine with 38:1 fatty acid | | PCe 38:2 | nmol/mg | Concentration of phosphatidylethanolamine with 38:2 fatty acid | | PCe 38:3 | nmol/mg | Concentration of phosphatidylethanolamine with 38:3 fatty acid | | PCe 38:4 | nmol/mg | Concentration of phosphatidylethanolamine with 38:4 fatty acid | | PCe 38:5 | nmol/mg | Concentration of phosphatidylethanolamine with 38:5 fatty acid | | PCe 38:6 | nmol/mg | Concentration of phosphatidylethanolamine with 38:6 fatty acid | | PCe 40:4 | nmol/mg | Concentration of phosphatidylethanolamine with 40:4 fatty acid | | PCe 40:5 | nmol/mg | Concentration of phosphatidylethanolamine with 40:5 fatty acid | | PCe 40:6 | nmol/mg | Concentration of phosphatidylethanolamine with 40:6 fatty acid | | PCe 40:7 | nmol/mg | Concentration of phosphatidylethanolamine with 40:7 fatty acid | | PCe 42:5 | nmol/mg | Concentration of phosphatidylethanolamine with 42:5 fatty acid | | PCe 42:6 | nmol/mg | Concentration of phosphatidylethanolamine with 42:6 fatty acid | | PCe 42:7 | nmol/mg | Concentration of phosphatidylethanolamine with 42:7 fatty acid | | PE 30:0 | nmol/mg | Concentration of phosphatidylethanolamine with 30:0 fatty acid | | PE 32:0 | nmol/mg | Concentration of phosphatidylethanolamine with 32:0 fatty acid | | PE 32:1 | nmol/mg | Concentration of phosphatidylethanolamine with 32:1 fatty acid | | PE 34:0 | nmol/mg | Concentration of phosphatidylethanolamine with 34:0 fatty acid | | PE 34:1 | nmol/mg | Concentration of phosphatidylethanolamine with 34:1 fatty acid | | PE 34:2 | nmol/mg | Concentration of phosphatidylethanolamine with 34:2 fatty acid | | PE 36:0 | nmol/mg | Concentration of phosphatidylethanolamine with 36:0 fatty acid | | PE 36:1 | nmol/mg | Concentration of phosphatidylethanolamine with 36:1 fatty acid | | PE 36:2 | nmol/mg | Concentration of phosphatidylethanolamine with 36:2 fatty acid | | PE 36:3 | nmol/mg | Concentration of phosphatidylethanolamine with 36:3 fatty acid | | PE 36:4 | nmol/mg | Concentration of phosphatidylethanolamine with 36:4 fatty acid | | PE 38:0 | nmol/mg | Concentration of phosphatidylethanolamine with 38:0 fatty acid | | PE 38:1 | nmol/mg | Concentration of phosphatidylethanolamine with 38:1 fatty acid | | PE 38:2 | nmol/mg | Concentration of phosphatidylethanolamine with 38:2 fatty acid | | PE 38:3 | nmol/mg | Concentration of phosphatidylethanolamine with 38:3 fatty acid | | PE 38:4 | nmol/mg | Concentration of phosphatidylethanolamine with 38:4 fatty acid | | PE 38:5 | nmol/mg | Concentration of phosphatidylethanolamine with 38:5 fatty acid | | PE 38:6 | nmol/mg | Concentration of phosphatidylethanolamine with 38:6 fatty acid | | PE 40:4 | nmol/mg | Concentration of phosphatidylethanolamine with 40:4 fatty acid | | PE 40:5 | nmol/mg | Concentration of phosphatidylethanolamine with 40:5 fatty acid | | PE 40:6 | nmol/mg | Concentration of phosphatidylethanolamine with 40:6 fatty acid | | PE 40:7 | nmol/mg | Concentration of phosphatidylethanolamine with 40:7 fatty acid | | PE 42:5 | nmol/mg | Concentration of phosphatidylethanolamine with 42:5 fatty acid | | PE 42:6 | nmol/mg | Concentration of phosphatidylethanolamine with 42:6 fatty acid | | PE 42:7 | nmol/mg | Concentration of phosphatidylethanolamine with 42:7 fatty acid | | PEp 30:0 | nmol/mg | Concentration of phosphatidylethanolamine with 30:0 fatty acid | | PEp 32:0 | nmol/mg | Concentration of phosphatidylethanolamine with 32:0 fatty acid | | PEp 32:1 | nmol/mg | Concentration of phosphatidylethanolamine with 32:1 fatty acid | | PEp 34:0 | nmol/mg | Concentration of phosphatidylethanolamine with 34:0 fatty acid | | PEp 34:1 | nmol/mg | Concentration of phosphatidylethanolamine with 34:1 fatty acid | | PEp 34:2 | nmol/mg | Concentration of phosphatidylethanolamine with 34:2 fatty acid | | PEp 36:0 | nmol/mg | Concentration of phosphatidylethanolamine with 36:0 fatty acid | | PEp 36:1 | nmol/mg | Concentration of phosphatidylethanolamine with 36:1 fatty acid | | PEp 36:2 | nmol/mg | Concentration of phosphatidylethanolamine with 36:2 fatty acid | | PEp 36:3 | nmol/mg | Concentration of phosphatidylethanolamine with 36:3 fatty acid | | PEp 36:4 | nmol/mg | Concentration of phosphatidylethanolamine with 36:4 fatty acid | | PEp 38:0 | nmol/mg | Concentration of phosphatidylethanolamine with 38:0 fatty acid | | PEp 38:1 | nmol/mg | Concentration of phosphatidylethanolamine with 38:1 fatty acid | | PEp 38:2 | nmol/mg | Concentration of phosphatidylethanolamine with 38:2 fatty acid | | PEp 38:3 | nmol/mg | Concentration of phosphatidylethanolamine with 38:3 fatty acid | | PEp 38:4 | nmol/mg | Concentration of phosphatidylethanolamine with 38:4 fatty acid | | PEp 38:5 | nmol/mg | Concentration of phosphatidylethanolamine with 38:5 fatty acid | | PEp 38:6 | nmol/mg | Concentration of phosphatidylethanolamine with 38:6 fatty acid | | PEp 40:4 | nmol/mg | Concentration of phosphatidylethanolamine with 40:4 fatty acid | | PEp 40:5 | nmol/mg | Concentration of phosphatidylethanolamine with 40:5 fatty acid | | PEp 40:6 | nmol/mg | Concentration of phosphatidylethanolamine with 40:6 fatty acid | | PEp 40:7 | nmol/mg | Concentration of phosphatidylethanolamine with 40:7 fatty acid | | PEp 42:5 | nmol/mg | Concentration of phosphatidylethanolamine with 42:5 fatty acid | | PEp 42:6 | nmol/mg | Concentration of phosphatidylethanolamine with 42:6 fatty acid | | PEp 42:7 | nmol/mg | Concentration of phosphatidylethanolamine with 42:7 fatty acid | | PS 30:0 | nmol/mg | Concentration of phosphatidylserine with 30:0 fatty acid | | PS 32:0 | nmol/mg | Concentration of phosphatidylserine with 32:0 fatty acid | | PS 32:1 | nmol/mg | Concentration of phosphatidylserine with 32:1 fatty acid | | PS 34:0 | nmol/mg | Concentration of phosphatidylserine with 34:0 fatty acid | | PS 34:1 | nmol/mg | Concentration of phosphatidylserine with 34:1 fatty acid | | PS 34:2 | nmol/mg | Concentration of phosphatidylserine with 34:2 fatty acid | | PS 36:0 | nmol/mg | Concentration of phosphatidylserine with 36:0 fatty acid | | PS 36:1 | nmol/mg | Concentration of phosphatidylserine with 36:1 fatty acid | | PS 36:2 | nmol/mg | Concentration of phosphatidylserine with 36:2 fatty acid | | PS 36:3 | nmol/mg | Concentration of phosphatidylserine with 36:3 fatty acid | | PS 36:4 | nmol/mg | Concentration of phosphatidylserine with 36:4 fatty acid | | PS 38:0 | nmol/mg | Concentration of phosphatidylserine with 38:0 fatty acid | | PS 38:1 | nmol/mg | Concentration of phosphatidylserine with 38:1 fatty acid | | PS 38:2 | nmol/mg | Concentration of phosphatidylserine with 38:2 fatty acid | | PS 38:3 | nmol/mg | Concentration of phosphatidylserine with 38:3 fatty acid | | PS 38:4 | nmol/mg | Concentration of phosphatidylserine with 38:4 fatty acid | | PS 38:5 | nmol/mg | Concentration of phosphatidylserine with 38:5 fatty acid | | PS 38:6 | nmol/mg | Concentration of phosphatidylserine with 38:6 fatty acid | | PS 40:4 | nmol/mg | Concentration of phosphatidylserine with 40:4 fatty acid | | PS 40:5 | nmol/mg | Concentration of phosphatidylserine with 40:5 fatty acid | | PS 40:6 | nmol/mg | Concentration of phosphatidylserine with 40:6 fatty acid | | PS 40:7 | nmol/mg | Concentration of phosphatidylserine with 40:7 fatty acid | | PS 42:5 | nmol/mg | Concentration of phosphatidylserine with 42:5 fatty acid | | PS 42:6 | nmol/mg | Concentration of phosphatidylserine with 42:6 fatty acid | | PS 42:7 | nmol/mg | Concentration of phosphatidylserine with 42:7 fatty acid | | PI 30:0 | nmol/mg | Concentration of phosphatidylinositol with 30:0 fatty acid | | PI 32:0 | nmol/mg | Concentration of phosphatidylinositol with 32:0 fatty acid | | PI 32:1 | nmol/mg | Concentration of phosphatidylinositol with 32:1 fatty acid | | PI 34:0 | nmol/mg | Concentration of phosphatidylinositol with 34:0 fatty acid | | PI 34:1 | nmol/mg | Concentration of phosphatidylinositol with 34:1 fatty acid | | PI 34:2 | nmol/mg | Concentration of phosphatidylinositol with 34:2 fatty acid | | PI 36:0 | nmol/mg | Concentration of phosphatidylinositol with 36:0 fatty acid | | PI 36:1 | nmol/mg | Concentration of phosphatidylinositol with 36:1 fatty acid | | PI 36:2 | nmol/mg | Concentration of phosphatidylinositol with 36:2 fatty acid | | PI 36:3 | nmol/mg | Concentration of phosphatidylinositol with 36:3 fatty acid | | PI 36:4 | nmol/mg | Concentration of phosphatidylinositol with 36:4 fatty acid | | PI 38:0 | nmol/mg | Concentration of phosphatidylinositol with 38:0 fatty acid | | PI 38:1 | nmol/mg | Concentration of phosphatidylinositol with 38:1 fatty acid | | PI 38:2 | nmol/mg | Concentration of phosphatidylinositol with 38:2 fatty acid | | PI 38:3 | nmol/mg | Concentration of phosphatidylinositol with 38:3 fatty acid | | PI 38:4 | nmol/mg | Concentration of phosphatidylinositol with 38:4 fatty acid | | PI 38:5 | nmol/mg | Concentration of phosphatidylinositol with 38:5 fatty acid | | PI 38:6 | nmol/mg | Concentration of phosphatidylinositol with 38:6 fatty acid | | PI 40:4 | nmol/mg | Concentration of phosphatidylinositol with 40:4 fatty acid | | PI 40:5 | nmol/mg | Concentration of phosphatidylinositol with 40:5 fatty acid | | PI 40:6 | nmol/mg | Concentration of phosphatidylinositol with 40:6 fatty acid | | PI 40:7 | nmol/mg | Concentration of phosphatidylinositol with 40:7 fatty acid | | PI 42:5 | nmol/mg | Concentration of phosphatidylinositol with 42:5 fatty acid | | PI 42:6 | nmol/mg | Concentration of phosphatidylinositol with 42:6 fatty acid | | PI 42:7 | nmol/mg | Concentration of phosphatidylinositol with 42:7 fatty acid | | PG 30:0 | nmol/mg | Concentration of phosphatidylglycerol with 30:0 fatty acid | | PG 32:0 | nmol/mg | Concentration of phosphatidylglycerol with 32:0 fatty acid | | PG 32:1 | nmol/mg | Concentration of phosphatidylglycerol with 32:1 fatty acid | | PG 34:0 | nmol/mg | Concentration of phosphatidylglycerol with 34:0 fatty acid | | PG 34:1 | nmol/mg | Concentration of phosphatidylglycerol with 34:1 fatty acid | | PG 34:2 | nmol/mg | Concentration of phosphatidylglycerol with 34:2 fatty acid | | PG 36:0 | nmol/mg | Concentration of phosphatidylglycerol with 36:0 fatty acid | | PG 36:1 | nmol/mg | Concentration of phosphatidylglycerol with 36:1 fatty acid | | PG 36:2 | nmol/mg | Concentration of phosphatidylglycerol with 36:2 fatty acid | | PG 36:3 | nmol/mg | Concentration of phosphatidylglycerol with 36:3 fatty acid | | PG 36:4 | nmol/mg | Concentration of phosphatidylglycerol with 36:4 fatty acid | | PG 38:0 | nmol/mg | Concentration of phosphatidylglycerol with 38:0 fatty acid | | PG 38:1 | nmol/mg | Concentration of phosphatidylglycerol with 38:1 fatty acid | | PG 38:2 | nmol/mg | Concentration of phosphatidylglycerol with 38:2 fatty acid | | PG 38:3 | nmol/mg | Concentration of phosphatidylglycerol with 38:3 fatty acid | | PG 38:4 | nmol/mg | Concentration of phosphatidylglycerol with 38:4 fatty acid | | PG 38:5 | nmol/mg | Concentration of phosphatidylglycerol with 38:5 fatty acid | | PG 38:6 | nmol/mg | Concentration of phosphatidylglycerol with 38:6 fatty acid | | PG 40:4 | nmol/mg | Concentration of phosphatidylglycerol with 40:4 fatty acid | | PG 40:5 | nmol/mg | Concentration of phosphatidylglycerol with 40:5 fatty acid | | PG 40:6 | nmol/mg | Concentration of phosphatidylglycerol with 40:6 fatty acid | | PG 40:7 | nmol/mg | Concentration of phosphatidylglycerol with 40:7 fatty acid | | PG 42:5 | nmol/mg | Concentration of phosphatidylglycerol with 42:5 fatty acid | | PG 42:6 | nmol/mg | Concentration of phosphatidylglycerol with 42:6 fatty acid | | PG 42:7 | nmol/mg | Concentration of phosphatidylglycerol with 42:7 fatty acid | | BMP 30:0 | nmol/mg | Concentration of bis(monoacylglycerol)phosphate with 30:0 fatty acid | | BMP 32:0 | nmol/mg | Concentration of bis(monoacylglycerol)phosphate with 32:0 fatty acid | | BMP 32:1 | nmol/mg | Concentration of bis(monoacylglycerol)phosphate with 32:1 fatty acid | | BMP 34:0 | nmol/mg | Concentration of bis(monoacylglycerol)phosphate with 34:0 fatty acid | | BMP 34:1 | nmol/mg | Concentration of bis(monoacylglycerol)phosphate with 34:1 fatty acid | | BMP 34:2 | nmol/mg | Concentration of bis(monoacylglycerol)phosphate with 34:2 fatty acid | | BMP 36:0 | nmol/mg | Concentration of bis(monoacylglycerol)phosphate with 36:0 fatty acid | | BMP 36:1 | nmol/mg | Concentration of bis(monoacylglycerol)phosphate with 36:1 fatty acid | | BMP 36:2 | nmol/mg | Concentration of bis(monoacylglycerol)phosphate with 36:2 fatty acid | | BMP 36:3 | nmol/mg | Concentration of bis(monoacylglycerol)phosphate with 36:3 fatty acid | | BMP 36:4 | nmol/mg | Concentration of bis(monoacylglycerol)phosphate with 36:4 fatty acid | | BMP 38:0 | nmol/mg | Concentration of bis(monoacylglycerol)phosphate with 38:0 fatty acid | | BMP 38:1 | nmol/mg | Concentration of bis(monoacylglycerol)phosphate with 38:1 fatty acid | | BMP 38:2 | nmol/mg | Concentration of bis(monoacylglycerol)phosphate with 38:2 fatty acid | | BMP 38:3 | nmol/mg | Concentration of bis(monoacylglycerol)phosphate with 38:3 fatty acid | | BMP 38:4 | nmol/mg | Concentration of bis(monoacylglycerol)phosphate with 38:4 fatty acid | | BMP 38:5 | nmol/mg | Concentration of bis(monoacylglycerol)phosphate with 38:5 fatty acid | | BMP 38:6 | nmol/mg | Concentration of bis(monoacylglycerol)phosphate with 38:6 fatty acid | | BMP 40:4 | nmol/mg | Concentration of bis(monoacylglycerol)phosphate with 40:4 fatty acid | | BMP 40:5 | nmol/mg | Concentration of bis(monoacylglycerol)phosphate with 40:5 fatty acid | | BMP 40:6 | nmol/mg | Concentration of bis(monoacylglycerol)phosphate with 40:6 fatty acid | | BMP 40:7 | nmol/mg | Concentration of bis(monoacylglycerol)phosphate with 40:7 fatty acid | | BMP 42:6 | nmol/mg | Concentration of bis(monoacylglycerol)phosphate with 42:6 fatty acid | | BMP 42:7 | nmol/mg | Concentration of bis(monoacylglycerol)phosphate with 42:7 fatty acid | | AcylPG 16:0-34:0 | nmol/mg | Concentration of acylphosphatidylglycerol with 16:0/34:0 fatty acid | | AcylPG 16:0-34:1 | nmol/mg | Concentration of acylphosphatidylglycerol with 16:0/34:1 fatty acid | | AcylPG 16:0-34:2 | nmol/mg | Concentration of acylphosphatidylglycerol with 16:0/34:2 fatty acid | | AcylPG 16:0-36:0 | nmol/mg | Concentration of acylphosphatidylglycerol with 16:0/36:0 fatty acid | | AcylPG 16:0-36:1 | nmol/mg | Concentration of acylphosphatidylglycerol with 16:0/36:1 fatty acid | | AcylPG 16:0-36:2 | nmol/mg | Concentration of acylphosphatidylglycerol with 16:0/36:2 fatty acid | | AcylPG 16:0-36:3 | nmol/mg | Concentration of acylphosphatidylglycerol with 16:0/36:3 fatty acid | | AcylPG 16:0-36:4 | nmol/mg | Concentration of acylphosphatidylglycerol with 16:0/36:4 fatty acid | | AcylPG 16:0-38:1 | nmol/mg | Concentration of acylphosphatidylglycerol with 16:0/38:1 fatty acid | | AcylPG 16:0-38:2 | nmol/mg | Concentration of acylphosphatidylglycerol with 16:0/38:2 fatty acid | | AcylPG 16:0-38:3 | nmol/mg | Concentration of acylphosphatidylglycerol with 16:0/38:3 fatty acid | | AcylPG 16:0-38:4 | nmol/mg | Concentration of acylphosphatidylglycerol with 16:0/38:4 fatty acid | | AcylPG 16:0-38:5 | nmol/mg | Concentration of acylphosphatidylglycerol with 16:0/38:5 fatty acid | | AcylPG 16:0-40:5 | nmol/mg | Concentration of acylphosphatidylglycerol with 16:0/40:5 fatty acid | | AcylPG 16:0-40:6 | nmol/mg | Concentration of acylphosphatidylglycerol with 16:0/40:6 fatty acid | | LPC 16:0 | nmol/mg | Concentration of lysophosphatidylcholine with 16:0 fatty acid | | LPC 16:1 | nmol/mg | Concentration of lysophosphatidylcholine with 16:1 fatty acid | | LPC 18:0 | nmol/mg | Concentration of lysophosphatidylcholine with 18:0 fatty acid | | LPC 18:1 | nmol/mg | Concentration of lysophosphatidylcholine with 18:1 fatty acid | | LPC 20:0 | nmol/mg | Concentration of lysophosphatidylcholine with 20:0 fatty acid | | LPC 20:1 | nmol/mg | Concentration of lysophosphatidylcholine with 20:1 fatty acid | | LPC 20:2 | nmol/mg | Concentration of lysophosphatidylcholine with 20:2 fatty acid | | LPC 20:3 | nmol/mg | Concentration of lysophosphatidylcholine with 20:3 fatty acid | | LPC 20:4 | nmol/mg | Concentration of lysophosphatidylcholine with 20:4 fatty acid | | LPCe 16:0 | nmol/mg | Concentration of lysophosphatidylethanolamine with 16:0 fatty acid | | LPCe 16:1 | nmol/mg | Concentration of lysophosphatidylethanolamine with 16:1 fatty acid | | LPCe 18:0 | nmol/mg | Concentration of lysophosphatidylethanolamine with 18:0 fatty acid | | LPCe 18:1 | nmol/mg | Concentration of lysophosphatidylethanolamine with 18:1 fatty acid | | LPCe 20:0 | nmol/mg | Concentration of lysophosphatidylethanolamine with 20:0 fatty acid | | LPCe 20:1 | nmol/mg | Concentration of lysophosphatidylethanolamine with 20:1 fatty acid | | LPCe 20:2 | nmol/mg | Concentration of lysophosphatidylethanolamine with 20:2 fatty acid | | LPCe 20:3 | nmol/mg | Concentration of lysophosphatidylethanolamine with 20:3 fatty acid | | LPCe 20:4 | nmol/mg | Concentration of lysophosphatidylethanolamine with 20:4 fatty acid | | LPE 16:0 | nmol/mg | Concentration of lysophosphatidylethanolamine with 16:0 fatty acid | | LPE 16:1 | nmol/mg | Concentration of lysophosphatidylethanolamine with 16:1 fatty acid | | LPE 18:0 | nmol/mg | Concentration of lysophosphatidylethanolamine with 18:0 fatty acid | | LPE 18:1 | nmol/mg | Concentration of lysophosphatidylethanolamine with 18:1 fatty acid | | LPE 20:0 | nmol/mg | Concentration of lysophosphatidylethanolamine with 20:0 fatty acid | | LPE 20:1 | nmol/mg | Concentration of lysophosphatidylethanolamine with 20:1 fatty acid | | LPE 20:2 | nmol/mg | Concentration of lysophosphatidylethanolamine with 20:2 fatty acid | | LPE 20:3 | nmol/mg | Concentration of lysophosphatidylethanolamine with 20:3 fatty acid | | LPE 20:4 | nmol/mg | Concentration of lysophosphatidylethanolamine with 20:4 fatty acid | | LPEp 16:0 | nmol/mg | Concentration of lysophosphatidylethanolamine (phosphatidylserine) with 16:0 fatty acid | | LPEp 16:1 | nmol/mg | Concentration of lysophosphatidylethanolamine (phosphatidylserine) with 16:1 fatty acid | | LPEp 18:0 | nmol/mg | Concentration of lysophosphatidylethanolamine (phosphatidylserine) with 18:0 fatty acid | | LPEp 18:1 | nmol/mg | Concentration of lysophosphatidylethanolamine (phosphatidylserine) with 18:1 fatty acid | | LPEp 20:0 | nmol/mg | Concentration of lysophosphatidylethanolamine (phosphatidylserine) with 20:0 fatty acid | | LPEp 20:1 | nmol/mg | Concentration of lysophosphatidylethanolamine (phosphatidylserine) with 20:1 fatty acid | | LPEp 20:2 | nmol/mg | Concentration of lysophosphatidylethanolamine (phosphatidylserine) with 20:2 fatty acid | | LPEp 20:3 | nmol/mg | Concentration of lysophosphatidylethanolamine (phosphatidylserine) with 20:3 fatty acid | | LPEp 20:4 | nmol/mg | Concentration of lysophosphatidylethanolamine (phosphatidylserine) with 20:4 fatty acid | | LPI 16:0 | nmol/mg | Concentration of lysophosphatidylinositol with 16:0 fatty acid | | LPI 16:1 | nmol/mg | Concentration of lysophosphatidylinositol with 16:1 fatty acid | | LPI 18:0 | nmol/mg | Concentration of lysophosphatidylinositol with 18:0 fatty acid | | LPI 18:1 | nmol/mg | Concentration of lysophosphatidylinositol with 18:1 fatty acid | | LPI 20:0 | nmol/mg | Concentration of lysophosphatidylinositol with 20:0 fatty acid | | LPI 20:1 | nmol/mg | Concentration of lysophosphatidylinositol with 20:1 fatty acid | | LPI 20:2 | nmol/mg | Concentration of lysophosphatidylinositol with 20:2 fatty acid | | LPI 20:3 | nmol/mg | Concentration of lysophosphatidylinositol with 20:3 fatty acid | | LPI 20:4 | nmol/mg | Concentration of lysophosphatidylinositol with 20:4 fatty acid | | LPS 16:0 | nmol/mg | Concentration of lysophosphatidylserine with 16:0 fatty acid | | LPS 16:1 | nmol/mg | Concentration of lysophosphatidylserine with 16:1 fatty acid | | LPS 18:0 | nmol/mg | Concentration of lysophosphatidylserine with 18:0 fatty acid | | LPS 18:1 | nmol/mg | Concentration of lysophosphatidylserine with 18:1 fatty acid | | LPS 20:0 | nmol/mg | Concentration of lysophosphatidylserine with 20:0 fatty acid | | LPS 20:1 | nmol/mg | Concentration of lysophosphatidylserine with 20:1 fatty acid | | LPS 20:4 | nmol/mg | Concentration of lysophosphatidylserine with 20:4 fatty acid | | LPS 22:0 | nmol/mg | Concentration of lysophosphatidylserine with 22:0 fatty acid | | LPS 22:1 | nmol/mg | Concentration of lysophosphatidylserine with 22:1 fatty acid | | LPS 24:0 | nmol/mg | Concentration of lysophosphatidylserine with 24:0 fatty acid | | LPS 24:1 | nmol/mg | Concentration of lysophosphatidylserine with 24:1 fatty acid | | NAPE 16:0/18:0/20:4 | nmol/mg | Concentration of N-acylphosphatidylethanolamine with 16:0, 18:0, and 20:4 fatty acids | | NAPE 18:0/18:1/20:4 | nmol/mg | Concentration of N-acylphosphatidylethanolamine with 18:0, 18:1, and 20:4 fatty acids | | NAPE 18:0/20:4/20:4 | nmol/mg | Concentration of N-acylphosphatidylethanolamine with 18:0, 20:4, and 20:4 fatty acids | | NAPE 18:0/22:6/20:4 | nmol/mg | Concentration of N-acylphosphatidylethanolamine with 18:0, 22:6, and 20:4 fatty acids | | NAPE 18:1/18:1/20:4 | nmol/mg | Concentration of N-acylphosphatidylethanolamine with 18:1, 18:1, and 20:4 fatty acids | | NAPE p16:0/18:0/20:4 | nmol/mg | Concentration of phosphorylated N-acylphosphatidylethanolamine with 16:0, 18:0, and 20:4 fatty acids | | NAPE p16:0/22:4/20:4 | nmol/mg | Concentration of phosphorylated N-acylphosphatidylethanolamine with 16:0, 22:4, and 20:4 fatty acids | | NAPE p18:0/18:1/20:4 | nmol/mg | Concentration of phosphorylated N-acylphosphatidylethanolamine with 18:0, 18:1, and 20:4 fatty acids | | NAPE p18:0/20:4/20:4 | nmol/mg | Concentration of phosphorylated N-acylphosphatidylethanolamine with 18:0, 20:4, and 20:4 fatty acids | | NAPE p18:0/22:4/20:4 | nmol/mg | Concentration of phosphorylated N-acylphosphatidylethanolamine with 18:0, 22:4, and 20:4 fatty acids | | NAPE p18:0/22:6/20:4 | nmol/mg | Concentration of phosphorylated N-acylphosphatidylethanolamine with 18:0, 22:6, and 20:4 fatty acids | | NAPE p18:1/18:1/20:4 | nmol/mg | Concentration of phosphorylated N-acylphosphatidylethanolamine with 18:1, 18:1, and 20:4 fatty acids | | NAPE p18:1/20:4/20:4 | nmol/mg | Concentration of phosphorylated N-acylphosphatidylethanolamine with 18:1, 20:4, and 20:4 fatty acids | | NAPS 16:0-36:0 | nmol/mg | Concentration of N-acylphosphatidylserine with fatty acids ranging from 16:0 to 36:0 | | NAPS 16:0-36:1 | nmol/mg | Concentration of N-acylphosphatidylserine with fatty acids ranging from 16:0 to 36:1 | | NAPS 16:0-36:2 | nmol/mg | Concentration of N-acylphosphatidylserine with fatty acids ranging from 16:0 to 36:2 | | NAPS 16:0-36:3 | nmol/mg | Concentration of N-acylphosphatidylserine with fatty acids ranging from 16:0 to 36:3 | | NAPS 16:0-36:4 | nmol/mg | Concentration of N-acylphosphatidylserine with fatty acids ranging from 16:0 to 36:4 | | NAPS 16:0-38:0 | nmol/mg | Concentration of N-acylphosphatidylserine with fatty acids ranging from 16:0 to 38:0 | | NAPS 16:0-38:1 | nmol/mg | Concentration of N-acylphosphatidylserine with fatty acids ranging from 16:0 to 38:1 | | NAPS 16:0-38:2 | nmol/mg | Concentration of N-acylphosphatidylserine with fatty acids ranging from 16:0 to 38:2 | | NAPS 16:0-38:3 | nmol/mg | Concentration of N-acylphosphatidylserine with fatty acids ranging from 16:0 to 38:3 | | NAPS 16:0-38:4 | nmol/mg | Concentration of N-acylphosphatidylserine with fatty acids ranging from 16:0 to 38:4 | | NAPS 16:0-38:5 | nmol/mg | Concentration of N-acylphosphatidylserine with fatty acids ranging from 16:0 to 38:5 | | NAPS 16:0-38:6 | nmol/mg | Concentration of N-acylphosphatidylserine with fatty acids ranging from 16:0 to 38:6 | | NAPS 16:0-40:4 | nmol/mg | Concentration of N-acylphosphatidylserine with fatty acids ranging from 16:0 to 40:4 | | NAPS 16:0-40:5 | nmol/mg | Concentration of N-acylphosphatidylserine with fatty acids ranging from 16:0 to 40:5 | | NAPS 16:0-40:6 | nmol/mg | Concentration of N-acylphosphatidylserine with fatty acids ranging from 16:0 to 40:6 | | NAPS 16:0-40:7 | nmol/mg | Concentration of N-acylphosphatidylserine with fatty acids ranging from 16:0 to 40:7 | | NSer 16:0 | nmol/mg | Concentration of N-serine with 16:0 fatty acid | | NSer 16:1 | nmol/mg | Concentration of N-serine with 16:1 fatty acid | | NSer 18:0 | nmol/mg | Concentration of N-serine with 18:0 fatty acid | | NSer 18:1 | nmol/mg | Concentration of N-serine with 18:1 fatty acid | | NSer 20:4 | nmol/mg | Concentration of N-serine with 20:4 fatty acid | | NSer 22:6 | nmol/mg | Concentration of N-serine with 22:6 fatty acid |